Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes

Blood. 2001 May 15;97(10):3017-24. doi: 10.1182/blood.v97.10.3017.

Abstract

Because hematopoietic cells derived from Fanconi anemia (FA) patients of the C-complementation group (FA-C) are hypersensitive to the inhibitory effects of interferon gamma (IFNgamma), the products of certain IFNgamma-inducible genes known to influence hematopoietic cell survival were quantified. High constitutive expression of the IFNgamma-inducible genes, IFN-stimulated gene factor 3 gamma subunit (ISGF3gamma), IFN regulatory factor-1 (IRF-1), and the cyclin-dependent kinase inhibitor p21(WAF1) was found in FANCC mutant B lymphoblasts, low-density bone marrow cells, and murine embryonic fibroblasts. Paradoxically, these cells do not activate signal transducer and activator of transcription (STAT) 1 properly. In an attempt to clarify mechanisms by which FA-C cells overexpress IFNgamma-inducible genes in the face of defective STAT1 phosphorylation, it was reasoned that decreased levels of activated STAT1 might result in reduced expression of a hematopoietic IFNgamma-responsive protein that normally modulates expression of other IFNgamma-responsive genes. Levels of the IFNgamma-inducible factor IFN consensus sequence binding protein (ICSBP), a negative trans-acting regulator of some IFNgamma-inducible genes, were quantified. ICSBP levels were reduced in FA-C B lymphoblasts and MEFs. However, enforced expression of ICSBP failed to down-regulate IRF-1, ISGF3gamma, and p21(WAF1). Thus, the FANCC protein functions to modulate expression of a family of genes that in normal cells are inducible only by specific environmental cues for apoptosis or mitogenic inhibition, but it does so independently of the classic IFN-STAT1 pathway and is not the direct result of reduced ICSBP expression.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • B-Lymphocytes / metabolism
  • Bone Marrow Cells / metabolism
  • Cell Cycle Proteins*
  • Cell Line, Transformed
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / genetics
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Embryo, Mammalian
  • Fanconi Anemia / genetics*
  • Fanconi Anemia / pathology
  • Fanconi Anemia Complementation Group C Protein
  • Fanconi Anemia Complementation Group Proteins
  • Fibroblasts / chemistry
  • Gene Expression Regulation*
  • Hematopoietic Stem Cells / pathology
  • Herpesvirus 4, Human
  • Humans
  • Interferon Regulatory Factor-1
  • Interferon Regulatory Factors
  • Interferon-Stimulated Gene Factor 3
  • Interferon-Stimulated Gene Factor 3, gamma Subunit
  • Interferon-gamma / pharmacology*
  • Mice
  • Mice, Knockout
  • Mutation
  • Nuclear Proteins*
  • Phosphoproteins / genetics
  • Phosphorylation
  • Proteins / genetics*
  • Proteins / physiology
  • Regulatory Sequences, Nucleic Acid
  • Repressor Proteins / analysis
  • STAT1 Transcription Factor
  • Trans-Activators / metabolism
  • Transcription Factors / genetics
  • Transfection

Substances

  • CDKN1A protein, human
  • Cdkn1a protein, mouse
  • Cell Cycle Proteins
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • DNA-Binding Proteins
  • FANCC protein, human
  • Fancc protein, mouse
  • Fanconi Anemia Complementation Group C Protein
  • Fanconi Anemia Complementation Group Proteins
  • IRF1 protein, human
  • IRF9 protein, human
  • Interferon Regulatory Factor-1
  • Interferon Regulatory Factors
  • Interferon-Stimulated Gene Factor 3
  • Interferon-Stimulated Gene Factor 3, gamma Subunit
  • Irf1 protein, mouse
  • Isgf3g protein, mouse
  • Nuclear Proteins
  • Phosphoproteins
  • Proteins
  • Repressor Proteins
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • Stat1 protein, mouse
  • Trans-Activators
  • Transcription Factors
  • interferon regulatory factor-8
  • Interferon-gamma